Outcomes of atypical lobular hyperplasia managed by active surveillance or immediate surgery.

Abstract

Atypical lobular hyperplasia (ALH) is typically diagnosed via needle core biopsy (NCB) and is commonly removed surgically in light of upgrade to malignancy rates of 1%-5%. As studies on radiographic outcomes of ALH managed by active surveillance (AS) are limited, we investigated the upgrade rates of surgically excised ALH as well as radiographic progression during AS. In this retrospective study, 125 patients with 127 ALH lesions diagnosed via NCB at Weill Cornell Medicine from 2015 to 2021 were included. The upgrade rate to cancer was determined for patients who had surgical management ≤6months after biopsy. Among patients with ALH managed by AS, we investigated radiographic progression on 6-month interval imaging. Of 127 ALH lesions, 75% (n=95) were immediately excised and 25% (n=32) were observed under AS. The upgrade rate of immediately excised ALH was 2.1% (n=2; invasive ductal carcinoma [IDC], T1N0 and IDC, and T1Nx). In the AS cohort, no ALH lesions progressed radiographically during the follow-up period of 22.5months (median), with all remaining stable (50%, n=16), resolving (47%, n=15), or decreasing in size (3%, n=1). In this study, NCB-diagnosed ALH had a low upgrade to malignancy rate (2.1%), and no ALH lesions managed by AS progressed radiographically during the follow-up period of 22.5months. These results support AS as the favorable option for patients with pure ALH on biopsy, with surgical excision for lesions that progress on surveillance.